| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $57K | — | -9.9% |
| SG&A Expense | $563K | — | -88.7% |
| Operating Income | -$563K | — | +88.7% |
| Interest Expense | $15K | — | +291.6% |
| Pre-tax Income | -$576K | — | +88.5% |
| Net Income | -$576K | — | +88.5% |
| EPS (Basic) | -$0.02 | — | +91.7% |
| EPS (Diluted) | -$0.02 | — | +91.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $146K | +218.1% | +1056.2% |
| Total Assets | $146K | +218.1% | +459.5% |
| Current Liabilities | $1.2M | -11.3% | -35.4% |
| Total Liabilities | $1.2M | -11.3% | -35.4% |
| Stockholders' Equity | -$1.1M | +19.3% | +42.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$194K | — | — |
| Financing Cash Flow | $260K | — | — |